On April 29, 2022, ShanXi C&Y Pharmaceutical Group Co., Ltd. closed the transaction. The company has received net proceeds of CNY 104,090,397.82 in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.55 CNY | +2.27% | +1.06% | -11.21% |
1st Jan change | Capi. | |
---|---|---|
-11.21% | 28Cr | |
+48.79% | 78TCr | |
+41.76% | 63TCr | |
+19.43% | 33TCr | |
+7.18% | 30TCr | |
+17.60% | 24TCr | |
-0.41% | 22TCr | |
+11.54% | 21TCr | |
+4.53% | 16TCr | |
-3.92% | 16TCr |
- Stock Market
- Equities
- 300254 Stock
- News ShanXi C&Y Pharmaceutical Group Co.,LTD.
- ShanXi C&Y Pharmaceutical Group Co., Ltd. announced that it has received CNY 109.999995 million in funding from Caitong Fund Management Co., Ltd., Ningbo Ningju Asset Management Center (Limited Partnership), Nuode Asset Management Co., Ltd., and other investors